BrightPath Biotherapeutics Co (TSE:4594) Float Percentage Of Total Shares Outstanding: 0.00% (As of Jul. 11, 2026)


TSE:4594 BrightPath Biotherapeutics Co Ltd TSE:4594
46 GF Score
Price 円50.00
GF Value 円4.64
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is BrightPath Biotherapeutics Co Float Percentage Of Total Shares Outstanding?

BrightPath Biotherapeutics Co TSE:4594 +2.04% 46 Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 11, 2026. GuruFocus rates TSE:4594 with a GF Score™ of 46/100 and a GF Value™ of 円4.64 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, BrightPath Biotherapeutics Co's float shares is 0.00 Mil. BrightPath Biotherapeutics Co's total shares outstanding is 138.89 Mil. BrightPath Biotherapeutics Co's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, BrightPath Biotherapeutics Co's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, BrightPath Biotherapeutics Co's Institutional Ownership is 0.13%.

TSE:4594
46GF Score
BrightPath Biotherapeutics Co Ltd TSE:4594
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BrightPath Biotherapeutics Co Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

BrightPath Biotherapeutics Co's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/138.89
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 0.00% mean?
BrightPath Biotherapeutics Co (TSE:4594) has a Float Percentage Of Total Shares Outstanding of 0.00% as of Jul. 11, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on BrightPath Biotherapeutics Co and its competitors.
Is BrightPath Biotherapeutics Co's Float Percentage Of Total Shares Outstanding too high?
BrightPath Biotherapeutics Co's current Float Percentage Of Total Shares Outstanding is 0.00%. Overall, BrightPath Biotherapeutics Co has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does BrightPath Biotherapeutics Co's Float Percentage Of Total Shares Outstanding compare to VRTX and REGN?
BrightPath Biotherapeutics Co's Float Percentage Of Total Shares Outstanding of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on BrightPath Biotherapeutics Co and its competitors. BrightPath Biotherapeutics Co's current Float Percentage Of Total Shares Outstanding is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BrightPath Biotherapeutics Co stock overvalued right now?
Based on GuruFocus' analysis, BrightPath Biotherapeutics Co (TSE:4594) is currently considered Significantly Overvalued. The stock's GF Value™ is 円4.64, compared to a current price of 円50.00 — trading 977.6% above its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 0.00%. BrightPath Biotherapeutics Co's overall GF Score™ is 46/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For BrightPath Biotherapeutics Co (TSE:4594), the current Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BrightPath Biotherapeutics Co (TSE:4594) Overvalued in 2026?

Based on GuruFocus' analysis, BrightPath Biotherapeutics Co stock appears to be overvalued. The current stock price of 円50.00 is trading 977.6% above its estimated GF Value™ of 円4.64. GuruFocus considers BrightPath Biotherapeutics Co to be Significantly Overvalued.

Key valuation signals for TSE:4594:

  • Float Percentage Of Total Shares Outstanding: 0.00%
  • GF Value™: 円4.64 vs. price of 円50.00 (977.6% above fair value)
  • GF Score™: 46/100 with 4 warning signs

No single metric tells the full story. See the TSE:4594 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BrightPath Biotherapeutics Co Business Description

Address 2-2-4 Kojimachi, Kojimachi Central Building 7th Floor, Chiyoda-ku, Tokyo, JPN
BrightPath Biotherapeutics Co Ltd is a biopharmaceutical venture company. It is engaged in developing novel cancer immunotherapeutics. Its products include two candidate products: ITK-1 and GRN-1201 which are in the clinical trial stage.
46GF Score

Get the complete analysis for TSE:4594

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円50.00
Price
円4.64
GF Value